Safety of regular formoterol or salmeterol in children with asthma
26 results
1 - 26
Safety of regular formoterol or salmeterol in children with asthma 
Safety of regular formoterol or salmeterol in children with asthma: an overview of Cochrane reviews- Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
- Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
- Diagnosis and treatment of childhood asthma
- Inhaled steroids with and without regular salmeterol for asthma: serious adverse events
- Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children: Cochrane systematic review
- Long‐acting beta2‐agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
- Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
- Vilanterol and fluticasone furoate for asthma
- Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
- Beta2‐agonists for exercise‐induced asthma
- Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth
- Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma
- Remote versus face‐to‐face check‐ups for asthma
- Leukotriene receptor antagonists as maintenance and intermittent therapy for episodic viral wheeze in children
- Individual‐level interventions to reduce personal exposure to outdoor air pollution and their effects on people with long‐term respiratory conditions